(Press-News.org) WINSTON-SALEM, N.C. – March 27, 2014 – Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer. The new research, published in Fertility and Sterility, the journal of the American Society for Reproductive Medicine, addresses the safety of an option scientists are developing for boys who aren't sexually mature and cannot bank sperm.
Scientists aim to freeze a sample of the boys' testicular tissue so that when they reach adulthood, spermatogonial stem cells (SSCs) found in the tissue can be reproduced and transplanted back into the patients. These cells are responsible for sperm production throughout adulthood.
"Our study addressed an important safety issue – whether cancer cells that might be present in testicular tissue samples can survive the process to replicate the sperm-producing stem cells," said lead author Hooman Sadri-Ardekani, M.D., Ph.D., an instructor in urology and regenerative medicine at Wake Forest Baptist Medical Center.
"This is an important consideration because of the potential to re-introduce cancer into the patient," he said. "The research, which involved one of the most common childhood cancers, shows that the cancer cells were eliminated. Based on these findings, we recommend that all boys with cancer be offered the option of storing testicular tissue for possible future clinical use."
Sadri-Ardekani performed the work with researchers at the University of Amsterdam and Avicenna Research Institute in Tehran, Iran, before joining Wake Forest Baptist.
Cancers that can have a high risk of infertility, depending on the treatment, are certain leukemias, Hodgkin's disease, brain tumors and bone cancer. Because of the high survival rates of childhood cancer – close to 80 percent – more cancer patients than ever are reaching adulthood and many face fertility problems.
The current research involved acute lymphoblastic leukemia (ALL) cells, a common type of childhood cancer. Previous research had shown that up to 30 percent of boys with ALL had cancer cells in their testicular tissue.
Several earlier studies have attempted to eliminate cancer cells from biopsy tissue, but they showed contradictory results. The approach of Sadri-Ardekani and colleagues was to investigate whether cancer cells would survive the laboratory protocol they had developed to reproduce SSCs from a small tissue biopsy. This process multiplies the original SSCs by 18,000-fold so there are enough cells to transplant back into the patient when he reaches adulthood.
For the research, ALL cells were taken from three patients' bone marrow. The team then put the ALL cells alone, and ALL cells combined with testicular cells, through the cell-reproduction process.
Even when ALL cells made up 40 percent of the cell mixture being cultured, they were entirely eliminated in 26 days of culture.
"This pilot study showed that the culture system not only allowed for efficient propagation of sperm stem cells, but also eliminated ALL cells," said Sadri-Ardekani.
SSC transplantation has not yet been attempted in humans, but has been performed successfully in several species of animals, including monkeys, said Sadri-Ardekani. He noted that before physicians and scientists begin offering SSC transplantation in patients, additional research will be needed, including whether other types of leukemia cells will also be eliminated in the cell-propagation process.
INFORMATION:
Co-researchers were Christa Homberg, M.Sc., and Ellen van der Schoot, M.D., Ph.D., Sanquin Research, Amsterdam, the Netherlands; and Toni M. M. van Capel, B.Sc., Henk van den Berg, M.D., Ph.D., Fulco van der Veen, M.D., Ph.D., Ans M.M. van Pelt, Ph.D., and Sjoerd Repping, Ph.D., University of Amsterdam.
Media Contacts: Karen Richardson, krchrdsn@wakehealth.edu, (336) 716-4453 or Main Number (336) 716-4587.
About the Wake Forest Institute for Regenerative Medicine
The Wake Forest Institute for Regenerative Medicine is dedicated to the discovery, development and clinical translation of regenerative medicine technologies. The institute has used biomaterials alone, cell therapies, and engineered tissues and organs for the treatment of patients with injury or disease. Institute scientists were the first in the world to engineer a replacement organ in the laboratory that was successfully implanted in patients. The Institute is based at Wake Forest Baptist Medical Center, a fully integrated academic medical center located in Winston-Salem, North Carolina. The institution comprises the medical education and research components of Wake Forest School of Medicine, the integrated clinical structure and consumer brand Wake Forest Baptist Health, which includes North Carolina Baptist Hospital and Brenner Children's Hospital, the commercialization of research discoveries through the Piedmont Triad Research Park, as well a network of affiliated community based hospitals, physician practices, outpatient services and other medical facilities.
Study shows promise of preserving fertility in boys with cancer
2014-03-27
ELSE PRESS RELEASES FROM THIS DATE:
Research from CHORI scientists demonstrates first genome methylation in fruit fly
2014-03-27
March 27, 2013, Oakland, CA – A group of scientists from Children's Hospital Oakland Research Institute and UC Berkeley report the first mapping of genome methylation in the fruit-fly Drosophila melanogaster in their paper "Genome methylation in D. melanogaster is found at specific short motifs and is independent of DNMT2 activity," published this month in Genome Research.
This paper represents a major advance in the study of DNA methylation in insects. No previous study has succeeded in pinpointing the location of DNA methylation in the fly genome. The common opinion ...
Natural history dying of neglect
2014-03-27
Natural history provides essential knowledge for human wellbeing, yet its research, use and instruction in academia, government agencies and non-government organizations is declining drastically.
Simon Fraser University ecologist Anne Salomon is among 17 authors of a new paper that claims this decline in the developed world could seriously undermine the world's progress in research, conservation and management.
The paper, Natural History's Place in Science and Society, evaluates the state of natural history research and use today. The journal BioScience has just published ...
Antidepressants during pregnancy linked to preterm birth
2014-03-27
BOSTON -- Antidepressant medications taken by pregnant women are associated with increased rates of preterm birth. This finding reinforces the notion that antidepressants should not be used by pregnant women in the absence of a clear need that cannot be met through alternative approaches, say researchers from Brigham and Women's Hospital, Vanderbilt University, MetroWest Medical Center, and Tufts Medical Center.
"Preterm birth is a major clinical problem throughout the world and rates have been increasing over the past two decades. At the same time, rates of antidepressant ...
Patient satisfaction scores in the ER are not affected by receipt of painkillers
2014-03-27
WASHINGTON — Factors other than receipt of painkillers – including opiates – in the emergency department appear to be more important to patient satisfaction, as reflected in an analysis of Press Ganey® patient surveys to be published online today in Annals of Emergency Medicine ("Lack of Association between Press Ganey® Emergency Department Patient Satisfaction Scores and Emergency Department Administration of Analgesic Medications").
"The lack of connection between painkillers and patient satisfaction is frankly the opposite of what we expected to find," said lead ...
Adult cancer drugs show promise against an aggressive childhood brain tumor
2014-03-27
(MEMPHIS, Tenn. – March 27, 2014) The quest to improve survival of children with a high-risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other cancers. The study was published today online ahead of print in the journal Cancer Cell.
Researchers demonstrated that the drugs pemetrexed and gemcitabine killed cells from mouse and human brain tumors, called group 3 medulloblastoma, growing in the laboratory. Medulloblastoma is diagnosed in about 400 children annually in ...
NJIT mathematician releases 2014 Major League Baseball projections
2014-03-27
As Opening Day rapidly approaches for most Major League Baseball teams, NJIT Associate Professor of Mathematical Sciences Bruce Bukiet has prepared his annual MLB projections for the upcoming season. And, to the chagrin of loyal Mets fan Bukiet, New York's National League club looks to be in store for a disappointing year. Bukiet, who developed a mathematical model for calculating expected MLB win totals that was published in Operations Research, forecasts a mere 68 wins and a last-place finish for the Metropolitans.
Bukiet's model can be used to project the number of ...
Congress budget pact good for global health but NIH cuts threaten US innovations
2014-03-27
Washington, DC (March 27, 2014)—While a ceasefire in Washington's budget wars has restored funding for a range of programs targeting global health threats like AIDS and tuberculosis (TB), the simultaneous underfunding of the world's biggest sponsor of global health research and development (R&D) puts future progress at risk, warns a new report from a coalition of nonprofit groups focused on advancing innovation to save lives. The Global Health Technologies Coalition (GHTC) released their annual policy report today at a Capitol Hill briefing.
"The end of political gridlock ...
Big brown bat males call 'dibs' on food
2014-03-27
VIDEO:
This is an animation of a recording from a trial with two male bats competing for prey. Red and blue each represent a bat (red = GR41 and blue =...
Click here for more information.
As big brown bats wake up from their winter slumber and start zooming around in pursuit of insects to eat, how do they coordinate their activities in the dark of night? For one thing, according to researchers who report their findings on March 27 in the Cell Press journal Current Biology, males ...
The multiplication of cells under close observation
2014-03-27
Our cells must grow and divide optimally to ensure that our bodies functions properly. It is essential, however, that these processes are carefully controlled in order to prevent unrestrained proliferation that can lead to the formation of tumours. David Shore, a professor at the Faculty of Sciences, University of Geneva (UNIGE), Switzerland, and his team have uncovered a cellular factor that regulates the timing of DNA replication. This molecule, called Rif1, ensures that only a fraction of the origins of DNA replication is activated at specified times of the cell cycle. ...
Scientists find potential target for treating mitochondrial disorders
2014-03-27
CAMBRIDGE, Mass. (March 27, 2014) – Mitochondria, long known as "cellular power plants" for their generation of the key energy source adenosine triphosphate (ATP), are essential for proper cellular functions. Mitochondrial defects are often observed in a variety of diseases, including cancer, Alzheimer's disease, and Parkinson's disease, and are the hallmarks of a number of genetic mitochondrial disorders whose manifestations range from muscle weakness to organ failure. Despite a fairly strong understanding of the pathology of such genetic mitochondrial disorders, efforts ...